Skip to content
MedCompare

Axitinib

Also known as Inlyta (us), Axinix (india)

Cancer & Oncology
Save $7,119/mo
266× cheaper

Axitinib is used alone to treat advanced renal cell carcinoma (RCC, a type of cancer that begins in the cells of the kidneys) in people who have not been treated successfully with another medication.

United States
$7,146
per month
India
$27
per month
You save
$7,119
99.62% cheaper in India
24.8K US scripts/yr$176.3M potential annual savings$177M US spend/yr
Building 3D structure…
Drag to rotate · 3D structureC22H18N4OS

SMILES: CNC(=O)C1=CC=CC=C1SC2=CC3=C(C=C2)C(=NN3)/C=C/C4=CC=CC=N4

Compare the price
US price$7,146per month
India price$27per month
You save$7,11999.62% less

Based on 30 units per month. US $238.19 vs India $0.90 per unit.

Total over 1 periodSave $7,119$7,146 → $27
Is travelling to India worth it?

The savings here are large enough that a trip may still come out ahead. Adjust the numbers to your own situation — every value is an editable estimate.

Medicine savings over 6 months
$42,713
Estimated travel cost
− $2,300
Net savings after travel
$40,413

Even after travel, you could come out ahead by about $40,413.

Assumptions: medicine savings = (US − India monthly price) × months. Travel cost = flights + hotel × nights + buffer. Excludes consultation fees, visas, and other costs. For information only — not medical, legal, or travel advice.

The bigger picture

Axitinib is filled about 24.8K times a year under Medicare Part D. At the prices above, that works out to roughly:

Est. annual US spend
$177M
If sourced from India
$665.1K
Potential annual savings
$176.3M
−100%

Rough estimate. Based on Medicare Part D prescription volume (not the entire US market) scaled by the representative monthly price — actual totals depend on dose, duration and coverage.